SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-14-001206
Filing Date
2014-02-28
Accepted
2014-02-28 15:37:12
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2013_actinium.htm 10-K 1767779
2 CERTIFICATION f10k2013ex31i_actinium.htm EX-31.1 9119
3 CERTIFICATION f10k2013ex31ii_actinium.htm EX-31.2 9864
4 CERTIFICATION f10k2013ex32i_actinium.htm EX-32.1 4832
5 CERTIFICATION f10k2013ex32ii_actinium.htm EX-32.2 4948
  Complete submission text file 0001213900-14-001206.txt   8573632

Data Files

Seq Description Document Type Size
6 XBRL atnm-20131231.xml EX-101.INS 1072935
7 XBRL atnm-20131231.xsd EX-101.SCH 79903
8 XBRL atnm-20131231_cal.xml EX-101.CAL 40408
9 XBRL atnm-20131231_def.xml EX-101.DEF 270286
10 XBRL atnm-20131231_lab.xml EX-101.LAB 616782
11 XBRL atnm-20131231_pre.xml EX-101.PRE 403711
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52446 | Film No.: 14654952
SIC: 6770 Blank Checks